Australia markets closed

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5970-0.0128 (-2.10%)
At close: 04:00PM EDT
0.5964 -0.00 (-0.10%)
After hours: 06:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
27,974
30,117
58,620
46,649
10,984
Selling general and administrative
11,622
12,585
12,296
15,020
7,775
Total operating expenses
37,622
40,499
70,916
61,669
18,759
Operating income or loss
-37,622
-40,499
-70,916
-61,669
-18,759
Interest expense
91
75
14
1,598
164
Total other income/expenses net
10,457
2,494
-2,725
-2,894
-223
Income before tax
-27,115
-37,882
-73,534
-66,048
-19,101
Income from continuing operations
-27,115
-37,882
-73,534
-66,048
-19,101
Net income
-27,115
-37,882
-73,534
-66,048
-19,101
Net income available to common shareholders
-27,115
-37,882
-73,534
-66,048
-19,101
Basic EPS
-12.90
-61.84
-165.92
-175.20
-103.20
Diluted EPS
-12.90
-61.84
-165.92
-175.20
-103.20
Basic average shares
4,059
612.527
443.211
378.708
186.527
Diluted average shares
4,059
612.527
443.211
378.708
186.527